Alamar Biosciences Q1 EPS $(1.74), Sales $26.035M

Benzinga Newsdesk www.benzinga.com Negative 96.7%

Neg 96.7% Neu 0% Pos 0%

Alamar Biosciences (NASDAQ:ALMR) reported quarterly losses of $(1.74) per share. The company reported $26.035 million in sales this quarter.